✦ LIBER ✦

COMPARISON OF LEVODOPA WITH CARBIDOPA OR BENSERAZIDE IN PARKINSONISM

✍ Scribed by Greenacre, J.K.; Coxon, A.; Petrie, A.; Reid, J.L.

Book ID: 123104554
Publisher: The Lancet
Year: 1976
Tongue: English
Weight: 498 KB
Volume: 308
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(76)92403-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BROMOCRIPTINE AND LEVODOPA (WITH OR WITH

BROMOCRIPTINE AND LEVODOPA (WITH OR WITHOUT CARBIDOPA) IN PARKINSONISM

✍ Kartzinel, Ronald; Teychenne, Paul; Gillespie, MarjorieM.; Perlow, Mark; Gielen, 📂 Article 📅 1976 🏛 The Lancet 🌐 English ⚖ 516 KB

Direct switch from levodopa/benserazide

Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson’s disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study

✍ Karla Eggert; Örjan Skogar; Khaled Amar; Liisa Luotonen; Mikko Kuoppamäki; Mika 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 335 KB

214. A retrospective study to compare th

214. A retrospective study to compare the tolerability of switching from levodopa/carbidopa or levodopa/benserazide to stalevo

✍ Rebecca Phair; Con Yiannikas 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Comparison of standard carbidopa–levodop

Comparison of standard carbidopa–levodopa and sustained-release carbidopa–levodopa in parkinson's disease: Pharmacokinetic and quality-of-life measures

✍ Dr. Rajesh Pahwa; Kelly Lyons; Desni McGuire; Paul Silverstein; Felix Zwiebel; M 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB

## Abstract We compared clinical, pharmacokinetic, and quality‐of‐life measures in patients with Parkinson's disease (PD) who were on standard carbidopa‐levodopa (Std‐L) and after conversion to sustained‐release carbidopa‐levodopa 50/200 (L‐CR). A total of 20 PD patients with motor fluctuations par

Double-blind trial of levodopa/carbidopa

Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease

✍ Robert A. Hauser; Michel Panisset; Giovanni Abbruzzese; Linda Mancione; Nalina D 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

## Abstract We performed a 39‐week, randomized, double‐blind, multicenter study to compare the efficacy, safety, and tolerability of levodopa/carbidopa/entacapone (LCE, Stalevo) with levodopa/carbidopa (LC, Sinemet IR) in patients with early Parkinson's disease (PD). Four hundred twenty‐three patie

Comparison of 200 mg retarded release le

Comparison of 200 mg retarded release levodopa/carbidopa – with 150 mg levodopa/carbidopa/entacapone application: pharmacokinetics and efficacy in patients with Parkinson’s disease

✍ T. Müller; L. Ander; K. Kolf; D. Woitalla; S. Muhlack 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 205 KB